Prepare for your visit
Evelyn Corley
Family · Grand Prairie, TX · NPI 1699177758
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,260.02
in general payments reported to CMS, 2019-2025 · $24.33 in 2025
The $24.33 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $331.71
- Boehringer Ingelheim Pharmaceuticals, INC. $328.20
- Lilly USA, LLC $306.26
- Abbott Laboratories $301.44
- Merck Sharp & Dohme LLC $136.65
- Glaxosmithkline, LLC. $101.71
Drugs and devices associated with these payments
Freestyle Libre 3 Ozempic Rybelsus Shingrix Otezla Repatha Entresto Jardiance Belsomra Steglatro Segluromet Qulipta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Evelyn Corley listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10947792/evelyn-corley